explore -WSS

explore

author：knowledge 2025-09-27 13:11:12 - browse：76329

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Sutter Health’s antitrust win overturned by appeals court

WSS

The most pressing bird flu mysteries scientists want answered

The cancer drug shortage isn’t new — and neither are the solutions

Hollywood unions extend contract negotiations for actors

The cancer drug shortage isn’t new — and neither are the solutions

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Novavax promises a turnaround & Lilly roils the obesity market

entertainment

explore

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FTC loses bid to block Novant's North Carolina hospital merger

Novavax promises a turnaround & Lilly roils the obesity market

ASCO Takeaways: Winners, snoozers, and the art of cancer care

BioMarin wins approval for gene therapy to treat hemophilia A

Senators tussle over abortion against the backdrop of a presidential campaign

In Memoriam: Notable people who died in 2023

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMS got Medicare Advantage quality rating wrong, judge rules

Wikipedia

New air purifier tech could be key to improving indoor air quality

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Tori Bowie and the unacceptable rates of Black maternal death

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Take antibiotics after sex, CDC recommends for certain risk groups

Wikipedia

focus

leisure time

entertainment